Serhei Kostevitch
Founder, CEO, President & Chairman @ Asbis
Limassol, Cyprus
Serhei Kostevitch is a seed investor at Asbis in Limassol focused on Biotechnology and Manufacturing. Serhei Kostevitch is the Founder, CEO, President & Chairman of Asbis. He previously worked at Minsk radio engineering university as scientific research. Serhei Kostevitch attended INSEAD.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Serhei Kostevitch invests in
Stages Serhei Kostevitch invests in
Countries Serhei Kostevitch invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Manufacturing 2 (67%)
- Hardware 1 (33%)
- Robotics 1 (33%)
- Software 1 (33%)
Stage
- Seed 2 (67%)
- Corporate Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Autonomics
|
Autonomics is developing a city cleaning solution to help municipalities make the urban environment a clean, healthy, and cozy place to live with robotics and AI. | Seed / Mar 11, 2026 | |
ProMed BioSciences
|
Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.Collagen products are developed under carefully controlled conditions in order to meet strict customer specifications of quality and suitability for a wide range of research, clinical and cosmetic applications. | $801.5K / Corporate Round / Nov 09, 2022 | |
EMBIO Diagnostics
|
Here’s a comprehensive description for **EMBIO Diagnostics**:---**EMBIO Diagnostics Ltd** is a cutting-edge deep-tech company specializing in **sensor technology** that ensures the safety and quality of air, water, and food. Based in **Nicosia, Cyprus**, EMBIO leverages advanced diagnostic tools and data-driven solutions to address criticalenvironmental challenges and enhance public health outcomes.### **Vision and Mission** - **Vision**: To revolutionize diagnostics with innovative technologies that foster a healthier and more sustainable future. - **Mission**: To deliver real-time, actionable insights through state-of-the-art sensor technology, empowering businesses, governments, and individuals to make informed decisions.---### **Core Products and Solutions**#### 1. **B.EL.D™ (Bio Electric Diagnostics)** - A portable chemical analyzer for **rapid diagnostics** in industries such as food safety, environmental monitoring, and healthcare. - **Key Features**: - Wireless and portable, with Bluetooth connectivity. - Real-time results within **3 minutes**. - No specialized training required for operation. - Cost-effective testing for allergens, contaminants, and more.#### 2. **airbeld™ System** - A comprehensive indoor air quality (IAQ) monitoring solution designed to: - Detect pollutants and harmful conditions in real-time. - Provide automated reports and notifications for actionable insights. - Integrate seamlessly with **Building Management Systems (BMS)**. - Includes advanced features like **EOS Insights**, which offers concise reports on environmental conditions.---### **Technological Advancements** EMBIO combines state-of-the-art **sensor technology**, **IoT integration**, and **AI-powered analytics** to provide real-time monitoring and predictive diagnostics. The company's solutions are designed to be user-friendly, efficient, and accessible, requiring minimal setup and expertise.---### **Global Impact** EMBIO Diagnostics is committed to addressing global sustainability and public health challenges by: - Reducing **environmental hazards**. - Enhancing **air, water, and food quality standards**. - Contributing to **research and policy-making** with accurate, real-time data.The company has established a global presence, delivering its solutions to markets across Europe, the Middle East, and beyond. By participating in initiatives like **Gitex Global 2024**, EMBIO showcases its leadership in **DeepTech** and its dedication to **sustainability**.---### **Collaborations and Innovations** EMBIO fosters partnerships with academic institutions, governments, and industry leaders to: - Advance research in diagnostics and environmental health. - Promote awareness of sustainability and safety standards. - Drive innovation through continuous R&D.---### **Leadership** Under the guidance of **Constantinos Loizou**, CEO of EMBIO Diagnostics, the company has become a pioneer in sensor technology. His vision has positioned EMBIO as a trusted name in global markets for tackling critical diagnostic challenges.---### **Why Choose EMBIO?** - **Cutting-Edge Technology**: Industry-leading tools for real-time monitoring and diagnostics. - **Commitment to Sustainability**: Solutions designed with environmental and social impact in mind. - **Global Expertise**: Proven track record of delivering impactful solutions across multiple industries.**Website**: **Headquarters**: Nicosia, Cyprus | $1.1M / Seed / Dec 23, 2021 |
Co-Investors
About Asbis
ASBIS Group is one of the leading distributors of Information Technology products in Europe, Middle East and Africa Emerging Markets: Central and Eastern Europe, the Baltic States, the Commonwealth of Independent States, the Middle East and Africa, combining a broad geographical reach with a wide range of products distributed on a"one-stop-shop" basis.
Asbis Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Serhei Kostevitch
Founder, CEO, President & Chairman
|
|||
Vili Tajnic
VAD Team Lead
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Serhei Kostevitch invest in?
Serhei Kostevitch invests primarily in Biotechnology, Manufacturing and Hardware startups, most often at Seed and Corporate Round stage. Most of the 3 investments tracked by Shizune back companies in Cyprus. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Serhei Kostevitch last invest?
The most recent investment recorded for Serhei Kostevitch closed in Mar 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
